Page 21 - ITPS-7-2
P. 21

INNOSC Theranostics and
            Pharmacological Sciences                                             Novel pharmacologic therapies for SAH



               doi: 10.1002/jbt.23346                          76.  Chang CZ,  Lin CL, Wu SC,  Kwan AL. Purpurogallin,  a
                                                                  natural phenol, attenuates high-mobility group box 1 in
            67.  Cao Y, Li Y, He C,  et al. Selective ferroptosis  inhibitor   subarachnoid hemorrhage induced vasospasm in a rat
               liproxstatin-1  attenuates  neurological  deficits  and  model. Int J Vasc Med. 2014;2014:254270.
               neuroinflammation after subarachnoid hemorrhage.
               Neurosci Bull. 2021;37:535-549.                    doi: 10.1155/2014/254270
               doi: 10.1007/s12264-020-00620-5                 77.  Chang CZ, Wu SC, Kwan AL, Lin CL. Rhinacanthin-C, A
                                                                  fat-soluble  extract  from  Rhinacanthus nasutus,  modulates
            68.  Chen J, Wang Y, Li M,  et  al. Netrin-1 alleviates   high-mobility group box 1-related neuro-inflammation and
               early brain injury by regulating ferroptosis via the   subarachnoid hemorrhage-induced brain apoptosis in a rat
               PPARγ/Nrf2/GPX4   signaling  pathway  following    model. World Neurosurg. 2016;86:349-360.
               subarachnoid  hemorrhage.  Transl  Stroke  Res.
               2024;15:219-237.                                   doi: 10.1016/j.wneu.2015.08.071
               doi: 10.1007/s12975-022-01122-4                 78.  Haruma J, Teshigawara K, Hishikawa T,  et al. Anti-high
                                                                  mobility group box-1 (HMGB1) antibody attenuates delayed
            69.  Wang H, Zhou Y, Zhao M, Yu L, Lin Y, Kang D. Ferrostatin-1   cerebral vasospasm and brain injury after subarachnoid
               attenuates brain injury in animal model of subarachnoid   hemorrhage in rats. Sci Rep. 2016;6:37755.
               hemorrhage via phospholipase A2 activity of PRDX6.
               Neuroreport. 2023;34:606-616.                      doi: 10.1038/srep37755
               doi: 10.1097/WNR.0000000000001931               79.  Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an
                                                                  endothelin receptor antagonist, in patients with aneurysmal
            70.  Gatti S, Lonati C, Acerbi F, et al. Protective action of NDP-  subarachnoid haemorrhage undergoing surgical clipping: A
               MSH  in  experimental  subarachnoid  hemorrhage.  Exp   randomised, double-blind, placebo-controlled phase 3 trial
               Neurol. 2012;234:230-238.                          (CONSCIOUS-2). Lancet Neurol. 2011;10:618-625.
               doi: 10.1016/j.expneurol.2011.12.039               doi: 10.1016/S1474-4422(11)70108-9
            71.  Fu S, Luo X, Wu X, et al., Activation of the melanocortin-1   80.  Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray
               receptor by  NDP-MSH  attenuates  oxidative stress and   GD; STASH Collaborators. Simvastatin in aneurysmal
               neuronal apoptosis through PI3K/Akt/Nrf2 pathway after   subarachnoid haemorrhage (STASH): A multicentre
               intracerebral hemorrhage in mice. Oxid Med Cell Longev.   randomised phase 3 trial. Lancet Neurol. 2014;13:666-675.
               2020;2020:8864100.
                                                                  doi: 10.1016/S1474-4422(14)70084-5
               doi: 10.1155/2020/8864100
                                                               81.  Dorhout Mees SM, Rinkel GJ, Feigin VL,  et al. Calcium
            72.  Carniglia L, Ramírez D, Durand D, Saba J, Caruso C, Lasaga   antagonists for aneurysmal subarachnoid haemorrhage.
               M. Nle4, D-Phe -α-MSH inhibits toll-like receptor (TLR)2-   Cochrane Database Syst Rev. 2007;3:CD000277.
                           7
               and TLR4-induced  microglial activation  and  promotes  a
               M2-like phenotype. PLoS One. 2016;11:e0158564.     doi: 10.1002/14651858.CD000277.pub3
               doi: 10.1371/journal.pone.0158564               82.  Wong  GK,  Poon  WS,  Chan  MT.  Intracranial  pressure
                                                                  monitoring in patients with aneurysmal subarachnoid
            73.  Li Y, Sun F, Jing Z, Wang X, Hua X, Wan L. Glycyrrhizic   hemorrhage: A systematic review. Stroke. 2013;44:e38-e40.
               acid exerts anti-inflammatory effect to improve cerebral
               vasospasm secondary to subarachnoid hemorrhage in a rat   83.  Connolly ES Jr., Rabinstein AA, Carhuapoma JR,  et  al.
               model. Neurol Res. 2017;39:727-732.                Guidelines for the management of aneurysmal subarachnoid
                                                                  hemorrhage:  A  guideline  for  healthcare  professionals
               doi: 10.1080/01616412.2017.1316903                 from the American Heart Association/American Stroke
            74.  Ieong C, Sun H, Wang Q, Ma J. Glycyrrhizin suppresses the   Association. Stroke. 2012;43:1711-1737.
               expressions of HMGB1 and ameliorates inflammative effect      doi: 10.1161/STR.0b013e3182587839
               after acute subarachnoid hemorrhage in rat model. J Clin   84.  Treggiari MM, Walder B, Suter PM, Romand JA. Systematic
               Neurosci. 2018;47:278-284.
                                                                  review of the prevention of delayed ischemic neurological
               doi: 10.1016/j.jocn.2017.10.034                    deficits with hypertension, hypervolemia, and hemodilution
            75.  Chang  CZ,  Wu  SC,  Kwan  AL.  Glycyrrhizin  attenuates   therapy  following  subarachnoid  hemorrhage.  J  Neurosurg.
               proinflammatory cytokines through a peroxisome     2003;98:978-984.
               proliferator-activated receptor-γ-dependent mechanism      doi: 10.3171/jns.2003.98.5.0978
               and  experimental  vasospasm  in  a  rat  model.  J  Vasc Res.   85.  Messina A, Robba C, Stocchetti N,  et al. Hemodynamic
               2015;52:12-21.
                                                                  management of acute brain injury caused by cerebrovascular
               doi: 10.1159/000381099                             diseases: A survey of the European Society of Intensive Care


            Volume 7 Issue 2 (2024)                         15                               doi: 10.36922/itps.2019
   16   17   18   19   20   21   22   23   24   25   26